MTATP6P24

Across TCGA pan-cancer cohorts, MTATP6P24 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MTATP6P24 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MTATP6P24 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTATP6P24 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LGG show a favorable association.

TGCT, UCEC, and THCA are the cancer types where MTATP6P24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	All	0.617	0.976	<.001	102	view →
UCEC	DFS	Tertile	All	0.417	0.673	<.001	42	view →
THCA	OS	Tertile	IV	0.790	0.986	.004	36	view →
BLCA	DFS	Tertile	IV	0.278	0.485	.014	27	view →
KIRC	DFS	Tertile	IV	0.266	0.616	.019	18	view →
UCS	DFS	Tertile	All	0.163	0.529	.033	18	view →
ACC	DFS	Tertile	III,IV	0.048	0.457	.015	18	view →
SKCM	DFS	Tertile	All	0.784	0.610	.031	6	view →
LGG	OS	Tertile	All	1.000	0.811	.044	3	view →
KIRP	DFS	Tertile	II,III,IV	1.000	0.460	.047	3	view →
LIHC	OS	Tertile	All	1.000	0.643	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MTATP6P24–TGCT (OS)

Open the TGCT breakdown →